Document is current

Any future updates will be listed below

Correction: Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population

Crossref DOI link: https://doi.org/10.1007/s00262-026-04360-9

Published Online: 2026-04-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark